Product image of Fiasp Flextouch (Insulin Aspart) supplied by GNH India

Fiasp Flextouch

Active Ingredient:
Insulin Aspart
Origin:
EU

Fiasp Flextouch (Insulin Aspart)

Fiasp Flextouch is a rapid-acting insulin aspart solution for subcutaneous use, designed for diabetes management. This prefilled pen offers precise dosing and portability, making it a convenient option for daily insulin therapy.

Manufacturer / TM Owner

Novo Nordisk A/S

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

  • Fiasp Flextouch is primarily used for the management of diabetes, including both type 1 and type 2 diabetes. It helps control blood sugar levels by mimicking the natural insulin response in the body. This rapid-acting insulin is often used around mealtimes to manage postprandial glucose levels.

Side Effects

  • Fiasp Flextouch works quickly to lower blood sugar levels after meals. Users may experience effects within 10-20 minutes of administration. Common effects include improved blood sugar control and reduced symptoms of hyperglycemia. Individual responses can vary based on dosage and personal health factors.

Precautions & Warnings

  • Fiasp Flextouch should be stored properly to maintain its efficacy. It is important to follow the manufacturer's guidelines for storage and handling. Users should be aware of potential hypoglycemia and monitor blood sugar levels regularly. Always consult a healthcare provider for personalized advice.

Avoid Interactions

  • Fiasp Flextouch may interact with other medications, including oral hypoglycemic agents and certain antibiotics. Alcohol consumption can also affect blood sugar levels and should be monitored. It is important to discuss all current medications with a healthcare provider to avoid potential interactions.

Frequently Asked Questions

Fiasp Flextouch is used for the management of diabetes, helping to control blood sugar levels, especially around mealtimes.

Fiasp Flextouch typically starts working within 10-20 minutes of administration, making it a rapid-acting insulin option.

Fiasp Flextouch may be used in combination with other diabetes medications, but it is important to consult a healthcare provider for personalized advice.

Common side effects may include hypoglycemia, injection site reactions, and changes in blood sugar levels.

Fiasp Flextouch should be stored according to the manufacturer's guidelines to maintain its efficacy and safety.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Insulin Aspart

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT